Clinical Trials Logo

Ptosis clinical trials

View clinical trials related to Ptosis.

Filter by:

NCT ID: NCT05746078 Recruiting - Ptosis Clinical Trials

Performance and Safety Assessment of SPRING THREAD® Elastic Tensor Thread in Patients With Mild to Moderate Facial Ptosis.

ESTES
Start date: February 16, 2023
Phase:
Study type: Observational

The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SPRING THREAD® elastic tensor thread. The study will evaluate the outcome of the SPRING THREAD® elastic tensor thread range over a period of 5 years.

NCT ID: NCT04714424 Recruiting - Clinical trials for Macular Degeneration

Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues

RTS1
Start date: November 13, 2019
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to compare the results of vision tests that are algorithmically derived and delivered through a virtual reality headset with those delivered through the existing technology standards (eg. Humphrey for field tests). Tests that the researchers will be conducting include vision field perimetry, Amsler, acuity chart, contrast- sensitivity and currently used office tests.

NCT ID: NCT04007276 Not yet recruiting - Glaucoma Clinical Trials

The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients

Start date: November 10, 2025
Phase: Phase 4
Study type: Interventional

Glaucoma represents a group of conditions that cause damage to the optic nerve and can lead to irreversible vision loss. Current treatments are aimed at lowering intraocular pressure while minimizing medication side effects. Lumify™ (Brimonidine Tartrate Ophthalmic Solution 0.025%) is an FDA-approved medication for alleviating eye redness, a common side effect of glaucoma medications. The purpose of this study is to evaluate the effect of Lumify™ on eye redness, intraocular pressure, and eyelid position in patients with glaucoma who are already using the Brimonidine 0.1%, 0.15% or 0.2% eye drops.

NCT ID: NCT03375879 Recruiting - Blepharoptosis Clinical Trials

Bandage Contact Lens in Post Operative Ptosis Patients

Start date: February 21, 2018
Phase: N/A
Study type: Interventional

This study is being conducted to determine whether the use of bandage contact lens after ptosis surgery provides any benefits for the patient or is unnecessary.

NCT ID: NCT03266081 Withdrawn - Epiphora Clinical Trials

Bupivacaine Epiphora Trial

Start date: April 2015
Phase: Phase 2
Study type: Interventional

The objective of this study is to investigate quantitative improvement in excessive tearing after administration of Bupivacaine, a local anesthetic, into the affected eyelids.

NCT ID: NCT02959697 Recruiting - Blepharoptosis Clinical Trials

Subconjunctival Injection of Local Anesthetic in Anterior Blepharoptosis Repair

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Blepharoptosis (ptosis) repair is a common and generally well tolerated surgical procedure usually performed using local anesthetic. However, a subset of patients appears to experience intraoperative pain/discomfort during ptosis repair using an anterior approach with subcutaneous local anesthetic. Posterior subconjuctival local anesthetic is currently used for eyelid procedures such as chalazion incision and drainage and full-thickness eyelid resections. The purpose of this study is to determine whether an additional subconjunctival injection of local anesthetic, through the posterior aspect of the eyelid, reduces intraoperative pain during anterior ptosis repair.

NCT ID: NCT02878694 Terminated - Ptosis Clinical Trials

Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft

TTT-PT-DOP
Start date: November 14, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Interventional , multicenter , comparative study. One eye receiving the cells and the contralateral eye as a negative control . If effectiveness following review of the primary endpoint and the advice of an independent expert committee , the experimental treatment will be offered to the patient to the contralateral eyelid. Objective is to restore muscle function levator muscle of the upper eyelid by providing a registry of autologous myoblasts from a non- clinically affected muscle .

NCT ID: NCT02761083 Withdrawn - Ptosis Clinical Trials

PMCF-study Using Novosyn® Quick Suture Material in Ophthalmic Surgery

OPHTHALNOQ
Start date: May 2016
Phase: Phase 4
Study type: Interventional

The aim of this study is to show that the performance of Novosyn® Quick suture material is comparable with standard suture material used in Ophthalmic surgery. In order to show that, various safety and efficacy parameters have been selected. The outcome regarding these parameters will be compared in 2 treatment groups. Active control group will receive Vicryl® Rapide and the treatment group Novosyn® Quick for ophthalmic surgery. It was decided to design this study as a randomized trial, because limited clinical evidence is available in the literature for the active control group (Vicryl® Rapide) which can be used for comparison. Eye operation will be randomly allocated on the left and right side (1:1) to both treatment groups. Patients undergoing elective, primary ophthalmic surgery (dacryocystorhinostomy, ectropion, entropion, ptosis, eyelid tumor resection, blepharoplasty)

NCT ID: NCT02376556 Completed - Dry Eye Syndrome Clinical Trials

The Effect of Eyelid Surgery on Dry Eye - a Prospective Study

Start date: March 2015
Phase:
Study type: Observational

The investigators aim to assess the effect of blepharoplasty with or without muller muscle resection on the symptoms of dry eye syndrome. this will be an observational study in which patients undergoing the aforementioned surgeries will be followed up and monitored for dry eye symptoms.

NCT ID: NCT02226016 Not yet recruiting - Ptosis Clinical Trials

Levator Muscle Strength Evaluation

Start date: September 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to assess a new technique of measurement for the levator muscle. this measurement may be applied during a clinical evaluation of eyelid malposition. our purpose is to quantify the levator muscle strength and to corelate it to standard levator muscle strength assessment techniques routinley used in the oculoplastic clinic.